BRAINE L’ALLEUD, Belgium--(BUSINESS WIRE)--Cardio³ BioSciences (www.cardio3bio.com) announced today the appointment of Patrick Jeanmart as its Chief Financial Officer (CFO), effective immediately. Most recently, Mr. Jeanmart was Vice President of Finance since April 2004 for IBA Molecular, a cancer diagnostic company with international headquarters in Louvain-la-Neuve, Belgium, where he led a team of eight finance controllers and accountants. Earlier in his career, he was an audit manager at Deloitte & Touche. Mr. Jeanmart holds a master’s degree in economics from the University of Namur (Belgium).
